No process analytic technology (PAT)-worthy method is without limitations. As Anna-Lena Heins, PhD, and colleagues (Technical University, Munich) note in a recent article, industrial bioprocess PAT is ...

The "U.S. Flow Cytometry Market Size, Share & Trends Analysis Report by Product (Software, Accessories), Technology (Cell-based, Bead-based), Application, End-use, Region, and Segment Forecasts, ...

Flow cytometry is well adept for use in routine cell analysis workflows, allowing for the high-throughput characterization of large cell populations. As a result, flow cytometry has established itself ...

With flow cytometry, as with many technologies that enjoy continuous use, we can see an evolution of capabilities. Spectral analysis, image capture, and artificial intelligence are just a few of the ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This ...

To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...

Flow cytometry is a single-cell analytical technique that uses fluorophore-labeled cell structures or biomarkers to differentiate between cell populations. Through this method, researchers detect the ...

FRANKLIN LAKES, N.J., Jan. 20, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that a study conducted in collaboration ...

Impedance flow cytometry measurements are adversely affected by the distance between the analyte and the sensing electrodes. By slightly squeezing the microfluidic channel, adapts the channel’s height ...

FRANKLIN LAKES, N.J., Aug. 9, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration agreement with Labcorp ...

Despite their success, significant challenges remain in developing and optimizing CAR-T therapies, particularly when broadening their use to solid tumors. Download this eBook to access our latest ...